Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors

被引:16
|
作者
Malek, Ehsan [1 ]
Kim, Byung-Gyu [2 ]
Driscoll, James J. [3 ,4 ]
机构
[1] Univ Hosp, Case Med Ctr, Seidman Canc Ctr, Div Hematol & Oncol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Pediat, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[3] Univ Cincinnati, Coll Med, Div Hematol & Oncol, Cincinnati, OH 45267 USA
[4] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Cincinnati, OH 45267 USA
来源
GENES | 2016年 / 7卷 / 10期
关键词
long non-coding RNA; multiple myeloma; myelomagenesis; proteasome; drug resistance; MICRORNA EXPRESSION; MOLECULAR-MECHANISMS; MULTIDRUG-RESISTANCE; REFRACTORY MYELOMA; GENE-EXPRESSION; CANCER; BORTEZOMIB; SURVIVAL; CLASSIFICATION; DEXAMETHASONE;
D O I
10.3390/genes7100084
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
While the clinical benefit of proteasome inhibitors (PIs) for multiple myeloma (MM) treatment remains unchallenged, dose-limiting toxicities and the inevitable emergence of drug resistance limit their long-term utility. Disease eradication is compromised by drug resistance that is either present de novo or therapy-induced, which accounts for the majority of tumor relapses and MM-related deaths. Non-coding RNAs (ncRNAs) are a broad class of RNA molecules, including long non-coding RNAs (lncRNAs), that do not encode proteins but play a major role in regulating the fundamental cellular processes that control cancer initiation, metastasis, and therapeutic resistance. While lncRNAs have recently attracted significant attention as therapeutic targets to potentially improve cancer treatment, identification of lncRNAs that are deregulated in cells resistant to PIs has not been previously addressed. We have modeled drug resistance by generating three MM cell lines with acquired resistance to either bortezomib, carfilzomib, or ixazomib. Genome-wide profiling identified lncRNAs that were significantly deregulated in all three PI-resistant cell lines relative to the drug-sensitive parental cell line. Strikingly, certain lncRNAs deregulated in the three PI-resistant cell lines were also deregulated in MM plasma cells isolated from newly diagnosed patients compared to healthy plasma cells. Taken together, these preliminary studies strongly suggest that lncRNAs represent potential therapeutic targets to prevent or overcome drug resistance. More investigations are ongoing to expand these initial studies in a greater number of MM patients to better define lncRNAs signatures that contribute to PI resistance in MM.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Identification of long non-coding RNAs in insects genomes
    Legeai, Fabrice
    Derrien, Thomas
    CURRENT OPINION IN INSECT SCIENCE, 2015, 7 : 37 - 44
  • [32] Identification of the conserved long non-coding RNAs in myogenesis
    Anupam Bhattacharya
    Simang Champramary
    Tanya Tripathi
    Debajit Thakur
    Ilya Ioshikhes
    Satyendra Kumar Singh
    Soumyadeep Nandi
    BMC Genomics, 22
  • [33] Neurotrophic Long Non-Coding RNAs and Multiple Sclerosis
    Kamal, Ahmed
    Swellam, Menha Mahmoud
    Shalaby, Nevin Mohieldin
    Darwish, Marwa K.
    El-Nahrery, Islam
    BIOCHEMISTRY AND CELL BIOLOGY, 2023, 101 (06)
  • [34] Deregulated Long Non-Coding RNAs (lncRNA) as Promising Biomarkers in Hidradenitis Suppurativa
    Radhakrishna, Uppala
    Ratnamala, Uppala
    Jhala, Devendrasinh D.
    Uppala, Lavanya V.
    Vedangi, Aaren
    Saiyed, Nazia
    Patel, Maulikkumar
    Shah, Sushma R.
    Rawal, Rakesh M.
    Jemec, Gregor B. E.
    Mazza, Tommaso
    Mazzoccoli, Gianluigi
    Damiani, Giovanni
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [35] Identification of imatinib-resistant long non-coding RNAs in gastrointestinal stromal tumors
    Yan, Jingyi
    Chen, Didi
    Chen, Xiaolei
    Sun, Xuecheng
    Dong, Qiantong
    Du, Zhou
    Wang, Tingting
    ONCOLOGY LETTERS, 2019, 17 (02) : 2283 - 2295
  • [36] THE LONG NON-CODING RNA ST3GAL6-AS1 DEREGULATED IN MULTIPLE MYELOMA
    Vinci, C.
    Taiana, E.
    Favasuli, V.
    Ronchetti, D.
    Agnelli, L.
    Manzoni, M.
    Galletti, S.
    Pelizzoni, F.
    Lionetti, M.
    Todoerti, K.
    Neri, A.
    HAEMATOLOGICA, 2018, 103 : S23 - S23
  • [37] Long Intergenic Non-Coding RNAs (lincRNA) Impacts Biology and Clinical Outcome in Multiple Myeloma
    Samur, Mehmet Kemal
    Rashid, Naim
    Cleynen, Alice
    Fulciniti, Mariateresa
    Sperling, Adam
    Minvielle, Stephane
    Anderson, Kenneth C.
    Parmigiani, Giovanni
    Avet-Loiseau, Herve
    Munshi, Nikhil C.
    BLOOD, 2014, 124 (21)
  • [38] Long non-coding RNAs in ovarian granulosa cells
    Jiajie Tu
    Yu Chen
    Zhe Li
    Huan Yang
    He Chen
    Zhiying Yu
    Journal of Ovarian Research, 13
  • [39] Long non-coding RNAs in stem cells and cancer
    Eades, Gabriel
    Zhang, Yong-Shu
    Li, Qing-Lin
    Xia, Ji-Xiang
    Yao, Yuan
    Zhou, Qun
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (02): : 134 - 141
  • [40] Long non-coding RNAs in the regulation of myeloid cells
    Xinyu Tian
    Jie Tian
    Xinyi Tang
    Jie Ma
    Shengjun Wang
    Journal of Hematology & Oncology, 9